Internal Medicine, Pulmonary Disease · Denver, CO
NPI
1700858065
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1400 Jackson St
Denver, CO, 80206
Phone (303) 388-4461
Groups this clinician bills Medicare through
Medicare paid, 2024
$37K
379 services
Medicare patients, 2024
220
Average age 74
Drug cost, 2024
$3.8M
1,104 prescriptions
Company payments, 2024
$10K
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Evans R Fernandezperez was code 99214 (office e&m - established), 203 times for 135 patients. In total Evans R Fernandezperez billed 379 services in 16 codes, and Medicare paid $37K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 203 | 135 | $74.25 | $15K |
| 99205 Office E&M - New | Facility | 70 | 70 | $142.42 | $9,969 |
| 99214 Office E&M - Established | Office | 36 | 29 | $103.50 | $3,726 |
| 99215 Office E&M - Established | Facility | 32 | 30 | $111.74 | $3,576 |
| 99291 Critical Care E&M | Facility | 17 | 11 | $174.50 | $2,966 |
By year: 2022 $32K for 330 services; 2023 $38K for 388 services; 2024 $37K for 379 services.
Medicare prescription drug claims, 2024
In 2024, the drug Evans R Fernandezperez prescribed most often to Medicare patients was Ofev (Nintedanib Esylate), with 255 prescriptions and refills. In total Evans R Fernandezperez wrote 1,104 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ofev Nintedanib Esylate | 255 | 255 | 27 | $3.4M |
| Pirfenidone Generic | 117 | 133 | 20 | $260K |
| Mycophenolate Mofetil Generic | 116 | 177 | 25 | $16K |
| Prednisone Generic | 104 | 177 | 46 | $890 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 61 | 71 | 20 | $1,642 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 61 | 71 | 13 | $45K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 59 | 131 | 16 | $495 |
| Spiriva Handihaler Tiotropium Bromide | 20 | 36 | Under 11 | $18K |
| Symbicort Budesonide/Formoterol Fumarate | 19 | 43 | Under 11 | $9,820 |
| Spiriva Respimat Tiotropium Bromide | 18 | 19 | Under 11 | $9,674 |
| Azithromycin Generic | 18 | 22 | Under 11 | $73.66 |
| Gabapentin Generic | 17 | 26 | Under 11 | $140 |
| Omeprazole Generic | 17 | 47 | Under 11 | $171 |
| Breo Ellipta Fluticasone/Vilanterol | 16 | 16 | Under 11 | $6,363 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 16 | 18 | Under 11 | $8,157 |
Brand drugs: 518 claims; generic drugs: 586 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Evans R Fernandezperez $10K ($10K in general payments such as food, travel and fees) from 2 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $10K.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $10K |
| United Therapeutics Corporation UTHR | 1 | $138 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.